Comments and Letters

  • Comments Regarding CMS Proposed Payment Determinations for CLFS 2013

    September 28, 2012
        September 28, 2012   Mr. Glenn McGuirk Centers for Medicare & Medicaid Services Center for Medicare 7500 Security Boulevard Mail Stop C4-01-26 Baltimore, Maryland 21244   Dear Mr. McGuirk:   The American Clinical Laboratory Association (“ACLA”) is pleased to offer its comments on the Centers for Medicare and Medicaid Services’ (“CMS’s” or “the agency’s”) preliminary payment decisions for new and reconsidered ClinicalContinue Reading »...
  • Comments on PFS Proposed Rule for CY 2013

    September 04, 2012
        September 4, 2012   Ms. Marilyn Tavenner, Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue, S.W. Washington, DC 20201   RE: CMS-1590-P; Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for CY 2013 – Proposed Rule   Dear Ms. Tavenner:   The American ClinicalContinue Reading »...
  • Comments Regarding ONC Lab Health IT Survey

    August 17, 2012
        August 17, 2012   COMMENTS OF THE AMERICAN CLINICAL LABORATORY ASSOCIATION ON OFFICE OF THE NATIONAL COORDINATOR FOR HEALTH INFORMATION TECHNOLOGY PROPOSED INFORMATION COLLECTION REQUEST REGARDING HEALTH INFORMATION EXCHANGE IN CLINICAL LABORATORIES   The American Clinical Laboratory Association (“ACLA”) appreciates the opportunity to offer its comments on the Office of the National Coordinator for Health Information Technology (“ONC”) proposed project, “National Survey on Health InformationContinue Reading »...
  • Letter to CMS Regarding POS Policy

    July 24, 2012
      July 24, 2012   Mr. Marc Hartstein Acting Director, Hospital and Ambulatory Policy Group Centers for Medicare & Medicaid Services Center for Medicare 7500 Security Boulevard Mail Stop C4-01-26 Baltimore, Maryland 21244   Dear Mr. Hartstein, The American Clinical Laboratory Association (ACLA) is writing to thank you and your colleagues for the time you took in March to discuss ACLA’s concerns about TransmittalContinue Reading »...
  • AIM Letter to Governor Cuomo Regarding NY Self Referral Bill

    July 20, 2012
      July 20, 2012 The Honorable Andrew M. Cuomo Governor of New York State NYS State Capitol Building Albany, NY 12224 RE: Assembly Bill 3551-A/Senate Bill 4660 Dear Governor Cuomo: The Alliance for Integrity in Medicare (AIM), a coalition of organizations committed to ending inappropriate physician self-referral, respectfully requests your veto of AB3551-A/SB4660. This legislation would undermine the New York State Public Health LawContinue Reading »...
  • Letter to Sen. Klobuchar Regarding TEST Act

    July 18, 2012
      July 18, 2012   The Honorable Amy Klobuchar United States Senate 302 Senate Hart Office Building Washington, DC 20510   Dear Senators Klobuchar:   The American Clinical Laboratory Association (ACLA) is pleased to offer our full and strong support for S. 3391, the Taking Essential Steps for Testing Act or TEST Act. This Bill would make a needed change to existing regulation benefittingContinue Reading »...
  • Letter to Rep. Grimm Regarding TEST Act

    July 13, 2012
        July 13, 2012   The Honorable Michael Grimm United States House of Representatives 512 Cannon House Office Building Washington, DC 20515   Dear Representative Grimm:   The American Clinical Laboratory Association (ACLA) is pleased to offer our full and strong support for H.R. 6118, the Taking Essential Steps for Testing Act or TEST Act. This Bill would make a needed change toContinue Reading »...
  • Comments Regarding ONC RFI – Conditions for Trusted Exchange

    June 27, 2012
      June 27, 2012 Dr. Farzad Mostashari Office of the National Coordinator for Health Information Technology Attn: Governance RFI Department of Health and Human Services Hubert H. Humphrey Building, Ste. 729D 200 Independence Avenue, SW Washington, DC 20201 RE: Nationwide Health Information Network: Conditions for Trusted Exchange, Request for Information Dr. Mostashari, The American Clinical Laboratory Association (“ACLA”) is pleased to submit this responseContinue Reading »...
  • Comments on PRN 2012

    June 13, 2012
      June 13, 2012 Robert Melillo, Chief Legislation and Regulation New Jersey Department of Banking and Insurance 20 West State Street P.O. Box 325 Trenton, New Jersey 08625-0325   Sent via e-mail to: LegsRegs@dobi.state.nj.us RE: PRN 2012-066, Proposed Amendments: N.J.A.C. 11:22-1.1, 1.2, and 1.4   Dear Mr. Melillo,   The American Clinical Laboratory Association (“ACLA”) appreciates the opportunity to comment on the above-referenced ruleContinue Reading »...
  • Letter to FACA Program Lead Regarding McCaslin Nomination HITSC 2012

    June 08, 2012
      June 8, 2012   MacKenzie Robertson FACA Program Lead Office of the National Coordinator 355 E Street, SW, Suite 310 Washington, D.C. 20024   Dear Mr. Robertson: American Clinical Laboratory Association June 8, 2012 As President of the American Clinical Laboratory Association (ACLA), I am writing to urge that you appoint a representative of the laboratory industry as a Member to the HealthContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18